Trisomy 21 is the presence of three copies of chromosome 21 instead of the usual two, and it is the genetic basis of Down syndrome. It occurs in roughly 1 in every 700 live births, making it the most common chromosomal condition in humans. The extra chromosome is not a simple on-off switch for a single trait; it alters the activity of hundreds of genes, with cascading effects on brain development, the immune system, the heart, the thyroid, and more. Understanding what that third copy actually does, and why its consequences vary so much from person to person, has turned out to be far more complex than researchers expected even a couple of decades ago.
How the Extra Chromosome Gets There
In the vast majority of cases, trisomy 21 arises from a mistake called nondisjunction: during egg or sperm formation, chromosome 21 fails to separate properly, so one resulting cell ends up with two copies and the other with none. If the cell carrying the extra copy is fertilized, the embryo starts life with three copies in every cell. Data from large registries show that this error is overwhelmingly maternal in origin, meaning it happens during egg formation. The link with maternal age is well established. Compared to women aged 20 to 24, women aged 40 and older are roughly 8 to 15 times more likely to have an egg with a chromosome 21 nondisjunction error, depending on whether the mistake occurs during the first or second stage of egg cell division.1PubMed Central. Maternal age and risk for trisomy 21 assessed by the origin of chromosome nondisjunction: a report from the Atlanta and National Down Syndrome Projects Paternal errors and mistakes after fertilization account for only a small minority of cases, and neither of those categories shows the same age effect.
The picture is more nuanced than “older eggs make more mistakes,” though. Research into the mechanics of egg cell division has found that the physical location where chromosomes exchange segments of DNA during meiosis matters. When that exchange happens too close to the tip of the chromosome, or when it does not happen at all, the chromosome is more likely to be mis-sorted. Maternal age interacts with this process: as women age, exchanges that occur in certain positions become increasingly risky for nondisjunction.2PubMed Central. Etiology of Down syndrome: Evidence for consistent association among altered meiotic recombination, nondisjunction, and maternal age across populations Studies tracking the location of these DNA exchanges across different age groups confirmed the pattern: in older women, the average position of the exchange shifts toward the middle of the chromosome, while a single exchange near the tip is a risk factor regardless of age.3PLoS Genetics. New Insights into Human Nondisjunction of Chromosome 21 in Oocytes
Three Genetic Variations, One Syndrome
Not every person with Down syndrome carries a full extra chromosome 21. There are three recognized genetic forms. Full trisomy 21, which accounts for about 95 percent of cases, means every cell has three complete copies. Robertsonian translocation trisomy occurs when the extra chromosome 21 material is physically attached to another chromosome, usually chromosome 14. This form can run in families because a parent may carry the fused chromosome without symptoms. Mosaic trisomy 21 occurs when only some cells have three copies while others have the typical two, usually because the nondisjunction happened after fertilization rather than before.
These distinctions are not merely academic. Mosaic trisomy 21 can produce a wide range of outcomes depending on the fraction of cells carrying the extra chromosome. In laboratory measurements of cell stress markers, individuals with full trisomy or translocation trisomy showed consistently elevated levels compared to controls, while those with mosaicism had levels that depended on the proportion of trisomic versus normal cells.4PubMed. Lipid peroxidation in Down syndrome caused by regular trisomy 21, trisomy 21 by Robertsonian translocation and mosaic trisomy 21 This helps explain why some individuals with mosaic trisomy 21 may have milder features or fewer medical complications.
What the Extra Chromosome Does Inside Cells
A longstanding question has been whether cells try to compensate for the extra chromosome by dialing down gene activity on the third copy. The answer, based on detailed gene-expression studies, is that they mostly do not. Research using cell lines from individuals with Down syndrome found that dosage compensation is nearly absent: the genes on chromosome 21 are expressed at roughly the expected 1.5-fold level, both at the stage where DNA is first read and in the final RNA products.5PubMed Central. Transcription dosage compensation does not occur in Down syndrome In the brain, this overexpression of chromosome 21 genes is accompanied by widespread disruption of gene activity across other chromosomes as well, suggesting that the extra copy creates a ripple effect far beyond chromosome 21 itself.6PubMed. Gene expression profiling in the adult Down syndrome brain
The cognitive features of Down syndrome appear early. Altered brain structure is already visible in newborns, pointing to disruptions during the earliest stages of fetal brain development.7PubMed Central. Consequences of trisomy 21 for brain development in Down syndrome Researchers are still working out exactly which of the overexpressed genes matter most, but the fact that the effects are already present at birth puts boundaries on when any future intervention would need to act.
Prenatal Screening and Its Limits
Non-invasive prenatal testing, which analyzes fragments of fetal DNA circulating in the mother’s blood, has become the frontline screening tool for trisomy 21 in many countries. A large meta-analysis of over 148,000 tests found that it detects about 99.4 percent of trisomy 21 pregnancies, with a specificity above 99.9 percent.8PubMed. The accuracy of cell-free fetal DNA-based non-invasive prenatal testing in singleton pregnancies: a systematic review and bivariate meta-analysis Those numbers sound almost perfect, but context matters. The test analyzes placental DNA, not fetal DNA directly, and the two do not always match. In rare cases of confined placental mosaicism, the placenta’s chromosomal makeup differs from the fetus, leading to either false positives or false negatives.
False negatives, where the test misses a trisomy 21 pregnancy, can also happen when there is not enough fetal DNA in the sample. In those situations the maternal DNA overwhelms the signal.9PubMed Central. A Case of False Negative NIPT for Down Syndrome-Lessons Learned This is why professional guidelines still classify the blood test as a screening tool, not a diagnostic one. Confirmation requires amniocentesis or chorionic villus sampling, which directly examine fetal chromosomes. The practical takeaway for expectant parents is that a negative screening result is highly reassuring but not a guarantee, and a positive result warrants confirmatory testing before making any decisions.
The Interferon Problem
One of the most consequential discoveries in recent trisomy 21 research involves the immune system. Chromosome 21 carries the genes for four interferon receptors, proteins that sit on the surface of immune cells and relay signals about viral threats. Having three copies means cells produce about 50 percent more of these receptors than usual. In people with Down syndrome, this overexpression shows up across all tested immune cell types.10Cell Reports. Mass Cytometry Reveals Global Immune Dysregulation in Adults with Down Syndrome
The excess interferon signaling does not just boost antiviral defenses; it puts the immune system in a state of chronic low-grade activation. One downstream effect is overproduction of kynurenine, a metabolic byproduct of the amino acid tryptophan, through a pathway driven by an enzyme that interferon signaling turns on.11Nature Communications. Trisomy 21 activates the kynurenine pathway via increased dosage of interferon receptors Kynurenine buildup has been linked to inflammation and may contribute to some of the autoimmune tendencies seen in Down syndrome. In a striking experiment using a mouse model of Down syndrome, researchers corrected the copy number of just the interferon receptor gene cluster back to two copies. This single change normalized antiviral responses, prevented heart defects, improved cognition, and reduced craniofacial abnormalities in the mice.12Nature Genetics. Triplication of the interferon receptor locus contributes to hallmarks of Down syndrome in a mouse model That result does not mean all of Down syndrome’s features flow from interferon receptor triplication, but it suggests this one locus punches well above its weight.
Heart Defects and Congenital Abnormalities
About 40 to 50 percent of babies born with trisomy 21 have a congenital heart defect, most commonly atrioventricular septal defects, where the walls separating the heart’s chambers do not form correctly. Researchers have tried to find common genetic variants on chromosome 21 or elsewhere that explain why some children with trisomy 21 develop heart defects while others do not. A genome-wide association study identified a few suggestive regions but found no single common variant with a large effect, meaning the risk is likely spread across many small genetic influences rather than one or two key genes.13G3 Genes|Genomes|Genetics. Genome-Wide Association Study of Down Syndrome-Associated Atrioventricular Septal Defects
Gastrointestinal problems are also common. Up to three-quarters of children with Down syndrome experience some form of gastrointestinal issue, ranging from reflux and swallowing difficulties to chronic constipation and Hirschsprung disease, in which nerve cells are missing from part of the large intestine. The rate of Hirschsprung disease in children with trisomy 21 is estimated at 2 to 15 percent, far higher than in the general population.
Thyroid Dysfunction
Thyroid problems are so frequent in Down syndrome that routine screening is part of standard care. The range of issues includes congenital hypothyroidism, subclinical hypothyroidism, autoimmune thyroid disease, and, less often, hyperthyroidism.14PubMed Central. Thyroid Disorders in Subjects with Down Syndrome: An Update In one observational study of 88 children with trisomy 21, about 40 percent had some form of thyroid dysfunction: roughly a fifth had congenital hypothyroidism, around 10 percent had transient thyroid abnormalities, and 9 percent developed acquired hypothyroidism later in childhood.15PubMed Central. Patterns of thyroid dysfunction in children with trisomy 21: an observational study
Autoimmune thyroid diseases, specifically Hashimoto’s thyroiditis and Graves’ disease, are both more common and appear earlier in life in people with Down syndrome compared to the general population.16PubMed Central. Autoimmune Thyroid Disease in Patients with Down Syndrome-Review The chronic interferon activation described earlier may be part of the explanation, since it creates an immune environment more prone to self-attack. Because thyroid dysfunction can worsen cognitive and developmental outcomes if untreated, regular blood tests are a practical necessity throughout life for people with trisomy 21.
The Alzheimer’s Connection
Down syndrome is the single strongest genetic risk factor for early-onset Alzheimer’s disease. The link is direct: the gene for amyloid precursor protein (APP), which produces the amyloid plaques that are a hallmark of Alzheimer’s, sits on chromosome 21. Having three copies means more APP, more amyloid production, and earlier plaque formation. By their 40s, virtually all adults with Down syndrome show the brain pathology of Alzheimer’s disease, though not all develop clinical dementia at the same age.17PubMed Central. Down syndrome and Alzheimer’s disease: common molecular traits beyond the amyloid precursor protein
A rare but informative piece of evidence comes from individuals with partial trisomy 21, where only part of chromosome 21 is present in triplicate. In one documented case, a person had partial trisomy 21 that did not include the APP gene region, and they did not develop Alzheimer’s disease despite having other features of Down syndrome. This case confirmed that APP triplication is necessary for the Alzheimer’s pathology seen in Down syndrome.18PubMed Central. Down Syndrome, Partial Trisomy 21, and Absence of Alzheimer’s Disease: The Role of APP Proteomic comparisons of amyloid plaques from people with Down syndrome, early-onset Alzheimer’s, and late-onset Alzheimer’s show that the plaque composition is broadly similar across all three groups, reinforcing the idea that the same disease process is at work.19PubMed Central. Comparison of the amyloid plaque proteome in Down syndrome, early-onset Alzheimer’s disease, and late-onset Alzheimer’s disease
An Unusual Cancer Profile
Trisomy 21 creates a strange split in cancer risk. Children with Down syndrome have a dramatically elevated risk of certain blood cancers, particularly acute megakaryoblastic leukemia, a rare form that arises from the cells that produce platelets. The mechanism involves a cooperation between the extra chromosome 21 and mutations in a gene called GATA1. Babies with Down syndrome sometimes develop a condition called transient leukemia in the newborn period, where abnormal blood cells proliferate and then resolve on their own. But the same GATA1 mutations found in transient leukemia can persist in latent form and give rise to full leukemia later in infancy or early childhood.20PubMed. GATA1 mutations in transient leukemia and acute megakaryoblastic leukemia of Down syndrome The combination of trisomy 21 and GATA1 mutations is so specific that researchers have shown the same leukemia can develop regardless of which event comes first: the trisomy or the GATA1 mutation.21PubMed Central. Germline GATA1s-generating mutations predispose to leukemia with acquired trisomy 21 and Down syndrome-like phenotype
Counterintuitively, most solid tumors are less common in adults with Down syndrome. The reasons are not fully understood, but the chronic interferon activation and other immune peculiarities of trisomy 21 may play protective roles against certain cancers. This duality, heightened risk for some cancers and reduced risk for others, makes Down syndrome a valuable natural model for understanding how chromosome dosage affects tumor biology.
Hearing, Breathing, and Sleep
Ear infections and fluid buildup in the middle ear (otitis media with effusion) are very common in children with trisomy 21. In one study, about 38 percent of children with Down syndrome had middle ear effusion, and those who did had meaningfully reduced hearing compared to those without it.22PubMed. Otitis media with effusion in children with in Down syndrome The susceptibility may partly stem from differences in the microbial community of the nasopharynx: children with Down syndrome show distinct shifts in their nasal and middle ear microbiota compared to other children.23PubMed Central. Otitis Media in Children with Down Syndrome Is Associated with Shifts in the Nasopharyngeal and Middle Ear Microbiotas
Obstructive sleep apnea affects a majority of people with Down syndrome. The anatomy plays a role: a smaller midface, a relatively large tongue, and narrower airways combine with the low muscle tone typical of trisomy 21 to make airway collapse during sleep much more likely.24PubMed Central. Obstructive sleep apnea in patients with Down syndrome: current perspectives Untreated sleep apnea can worsen daytime attention, behavior, and learning, making screening and treatment an important part of care.
Fertility
Men with Down syndrome are almost always infertile, primarily due to defects in sperm production. Women with Down syndrome generally retain some fertility, though they tend to experience early menopause.25PubMed Central. Down syndrome and infertility: what support should we provide? In mouse models of Down syndrome, researchers found reduced sperm counts and abnormal sperm shape, along with large numbers of gene-expression changes in testicular tissue, particularly in pathways involved in sperm development and hormone production.26PubMed Central. Transcriptome analyses reveal the fertility defect in the Dp(16)1Yey/+ mouse model of Down syndrome Laboratory work with stem cells from individuals with Down syndrome has pointed to reduced expression of key genes involved in the earliest stages of germ cell formation, suggesting the problem starts very early in reproductive cell development.27PubMed. NANOS3 downregulation in Down syndrome hiPSCs during primordial germ cell-like cell differentiation
Experimental Therapies on the Horizon
Two research directions stand out for their ambition. The first targets a specific enzyme called DYRK1A, which is encoded on chromosome 21 and therefore overproduced in trisomy 21. In mouse models, inhibiting DYRK1A improved memory and learning performance across multiple genetic backgrounds of Down syndrome mice.28PubMed Central. Correction of cognitive deficits in mouse models of Down syndrome by a pharmacological inhibitor of DYRK1A Newer synthetic inhibitors have confirmed the effect: treated mice performed significantly better on maze tasks than untreated ones.29Scientific Reports. DYRK1A inhibition and cognitive rescue in a Down syndrome mouse model are induced by new fluoro-DANDY derivatives A clinical trial using epigallocatechin gallate, a compound found in green tea that inhibits DYRK1A, showed modest improvements in visual recognition memory and working memory in young people with Down syndrome.30PubMed Central. DYRK1A Protein, A Promising Therapeutic Target to Improve Cognitive Deficits in Down Syndrome These results are promising but preliminary, and the effect sizes are modest enough that no DYRK1A inhibitor is near clinical use for Down syndrome.
The second approach is more radical: silencing the entire extra chromosome. Researchers have shown that inserting the gene for XIST, a molecule that naturally silences one of the two X chromosomes in female mammals, into the extra chromosome 21 in lab-grown cells can broadly suppress its gene activity. When this was tested in stem cells that were then coaxed to develop into blood-forming cells, it corrected the overproduction of certain blood cell types that underlies the leukemia risk in Down syndrome.31PubMed Central. Trisomy silencing by XIST normalizes Down syndrome cell pathogenesis demonstrated for hematopoietic defects in vitro More recent work using CRISPR-based tools to integrate the XIST gene more efficiently showed partial correction of the gene-expression imbalance across the extra chromosome.32PubMed Central. A modified CRISPR/Cas9 approach in silencing the triplication in Down syndrome: A treatment path XISTs Chromosome silencing remains a lab technique, far from therapeutic application in a living person, but it offers a proof of concept that the genetic imbalance of trisomy 21 is in principle reversible at the cellular level.
Trisomy 21 in Other Species and in Antiquity
Humans are not the only primates affected. Chimpanzee chromosome 22 is the counterpart of human chromosome 21, and trisomy of that chromosome has been documented in captive chimpanzees. The clinical picture is strikingly similar: affected animals showed growth delays, congenital heart defects, cataracts, and dental abnormalities matching what is seen in human Down syndrome.33PubMed. Chimpanzee Down syndrome: a case study of trisomy 22 in a captive chimpanzee Molecular probes confirm that the Down syndrome critical region on human chromosome 21 is conserved in the same position on the equivalent chromosome in chimpanzees, gorillas, and orangutans.34Gene. Conservation of the Down syndrome critical region in humans and great apes
Looking backward in time, an ambitious ancient DNA study screened nearly 10,000 prehistoric and historic human remains for chromosomal abnormalities. The researchers identified six clear cases of trisomy 21, all found in infant or perinatal burials, spanning sites across thousands of years.35Nature Communications. Cases of trisomy 21 and trisomy 18 among historic and prehistoric individuals discovered from ancient DNA The burial practices around these infants varied, but the fact that they were buried with care suggests that communities recognized and responded to these individuals rather than simply discarding them. The finding also confirms that trisomy 21 is not a modern phenomenon related to environmental exposures or lifestyle changes; it is an ancient feature of human reproduction, rooted in the mechanics of how chromosomes are sorted every time an egg cell is made.